PRMT5 and leukemia: In MDS1 and EVI1 complex locus (EVI1)-overexpressing leukemia, PRMT5 inhibition decreased the levels of the spliced cytoplasmic form of activating transcription factor 4 (ATF4) protein, resulting in increased oxidative stress, growth arrest and senescence [116].